| Characteristics | No. (%) |
|---|
| Age at admission, mean (min–max) | 68 (22–94) |
| Gender |
| F | 137 (40.2) |
| M | 204 (59.8) |
| Neoadjuvant chemotherapy |
| No | 226 (66.3) |
| Yes | 115 (33.7) |
| Type of surgery (n) |
| Elective | 278 (81.5) |
| Reoperations | 63 (18.5) |
| ASA |
| 2 | 139 (40.9) |
| 3 | 176 (51.7) |
| 4 | 25 (7.4) |
| Surgical category |
| Colorectal | 103 (30.2) |
| Esophageal–gastric | 60 (17.6) |
| Hepatic | 46 (13.5) |
| Urgent laparotomies | 47 (13.8) |
| Hyperthermic intraperitoneal chemotherapy (HIPEC) | 40 (11.7) |
| Pancreatic | 19 (5.6) |
| Other | 26 (7.6) |
| Overall complications | 181 (53.1) |
| Clavien-Dindo classification |
| Grade I | 14 (7.7) |
| Grade II | 82 (45.3) |
| Grade IIIA | 24 (13.3) |
| Grade IIIB | 25 (13.8) |
| Grade IVA | 10 (5.5) |
| Grade IVB | 12 (6.6) |
| Grade V | 14 (7.7) |
| Mortality |
| 30 D | 12 (3.5) |
| 90 D | 22 (6.5) |
